HIGHLIGHTS
- who: ufeffYaufeff ufeffPengufeff from the Uppsala University, Recherche Mu00e9dicale (INSERM), France have published the Article: Advances in brain-heart syndrome: Attention to cardiac complications after ischemic stroke, in the Journal: (JOURNAL)
- how: Guangzheng Wu treated 70 patients with brain-heart syndrome treated by alprostadil intravenous therapy and the results showed that compared with conventional treatment the level of myocardial injury markers and inflammatory indicators in patients after treatment was significantly reduced which confirmed that alprostadil could increase coronary blood flow protect cardiomyocytes and inhibit inflammatory response (Bonnin et_al 2018).
- future: Increased coagulation and . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.